KURA

Kura Oncology is a drugmaker developing medicines to treat cancer and related diseases. The company's first approved product is KOMZIFTI, a pill that blocks a protein called menin, which is involved in certain blood cancers. They are also testing other menin-blocking drugs in combination with other therapies to treat solid tumors, as well as exploring menin inhibitors for diabetes and heart-related conditions. The company is based in San Diego, California.